SEC Form 4 · accession 0001127602-15-029615
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan White
Officer — Chief Science and Technology
Period of report
Oct 23, 2015
Accepted (ET)
Oct 27, 2015 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 23, 2015 | S | 250 | $31.7495 | D | 29,848 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale required by Haemonetics policy for tax withholding purposes.